So [systems] need to take an active participation or they will, I think, lose some patients to other systems or outside entities. The workforce challenges The first task in responding to the impact of GLP drugs is training, organizing and aligning the workforce to accommodate the major disruption coming their way, given the demographics of patients and their weight
GLP-1s can also trigger nausea, cramping or diarrhoea in some people meaning not everyone with IBS-D will benefit
Clinical trials have shown that Wegovy can help patients lose weight significantly
Whats happening: Eli Lilly has formally challenged the U.S
271 : 985991 Maltby N, Broe GA, Creasey H, Jorm AF, Christensen H, Brooks WS
It helps protect the skin from external factors and prevents oxidative stress, effectively safeguarding skin cells